MedTrace Logo

Longitudinal Study of Multi-Analyte Profile for Dyslipidemia

NCT01441908 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2012-04-16

No results posted yet for this study

Summary

The primary objective of this study is to determine any changes in cardiovascular risk among individuals receiving a statin by assessing their multi-analyte profile.

Conditions

Interventions

DRUG

Pravastatin

40mg or 80mg dose 28 days for 6 month period

Sponsors & Collaborators

  • MaiHealth Inc

    lead OTHER

Principal Investigators

  • Wayne Harper, MD · Wake Research Associates

  • Stephen Naylor, Ph.D. · MaiHealth Inc

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01441908 on ClinicalTrials.gov